ArticleCancers2026

Clinical and Biological Factors Associated with Pseudoprogression Under Immune Checkpoint Inhibitors: A Retrospective Pan-Tumor Cohort Study.

Amélie Toulet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.